Neogen (NEOG) EBT Margin (QoQ) (2010 - 2026)
Neogen (NEOG) EBT Margin (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -55.00 |
| Nov 30, 2025 | -3,000.00 |
| Aug 31, 2025 | 30,091.00 |
| May 31, 2025 | -27,558.00 |
| Feb 28, 2025 | 20,169.00 |
| Nov 30, 2024 | -19,888.00 |
| Aug 31, 2024 | -449.00 |
| May 31, 2024 | -16.00 |
| Feb 29, 2024 | -91.00 |
| Nov 30, 2023 | -236.00 |
| Aug 31, 2023 | -244.00 |
| May 31, 2023 | 420.00 |
| Feb 28, 2023 | 1,378.00 |
| Nov 30, 2022 | -1,985.00 |
| Aug 31, 2022 | -847.00 |
| May 31, 2022 | 832.00 |
| Feb 28, 2022 | -473.00 |
| Nov 30, 2021 | -703.00 |
| Aug 31, 2021 | 112.00 |
| May 31, 2021 | 212.00 |